Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: James Hutton who wrote (537)	12/17/1997 3:32:00 PM
From: Michael	Read Replies (1) \| Respond to of 3202

FYI, INCYTE PHARMACEUTICALS DIRECTOR FILES SEC FORM 4 December 17, 1997 States News Service via Individual Inc. : WASHINGTON, DC, Dec. 16, 1997 (States) -- Jeffrey J. Collinson of Stamford, CT, a Director of Incyte Pharmaceuticals (SYMBOL:INCY), disposed of 20,000 shares for $42.00 each on November 12, 1997. Jeffrey J. Collinson currently owns 249,878 shares. A Form 4 reporting the transaction was filed with the Securities and Exchange Commission on December 08, 1997.